Tag

Donald Trump Archives — Protect Our Care

Protect Our Care Statement on President Trump’s Shameful Attacks Against John McCain Over His Vote to Save Health Care

Washington, DC – After Donald Trump again insulted the memory of the late senator John McCain today over his vote to stop health care repeal Protect Our Care chair Leslie Dach released the following statement:

“Donald Trump’s latest attack against John McCain is a clear reminder that he remains obsessed with repealing and sabotaging our health care. The president is so intent on repealing health care protections, including those for people with pre-existing conditions, that he’s doubled down on his revenge vendetta against a true American war hero.”

SOTU Excerpts On Drug Prices: Same Exact Promise As Last Year, Expect the Same Inaction

Trump’s pledge on lowering prescription drug prices looks familiar…

“It is unacceptable that Americans pay vastly more than people in other countries for the exact same drugs, often made in the exact same place. This is wrong, unfair, and together we can stop it.”

…where have we heard this before? Ah yes, last year’s State of the Union.

“One of my greatest priorities is to reduce the price of prescription drugs. In many other countries, these drugs cost far less than what we pay in the United States. That is why I have directed my Administration to make fixing the injustice of high drug prices one of our top priorities. Prices will come down.”

Donald Trump: Cheap Talk. Sky High Drug Prices.

THE TRUMP ADMINISTRATION IS ALL TALK ON DRUG PRICES, BUT NO ACTION:

Drug Prices Continue to Soar Under Trump. A report by Senate Democrats finds that the prices of the 20 most-prescribed drugs under Medicare Part D have increased substantially over the past five years, rising 10 times faster than inflation. Another report from the Pharmacy Benefits Consultants finds that drug prices soared over the first 14 months of Trump’s presidency, during which 20 prescription drugs saw list-price increases of more than 200 percent. In 2018, there were about 1,800 prescription drug price increases according to data compiled by 46brooklyn Research. This year already, Pharma giants Pfizer and Novartis have raised prices on dozens of drug.

Trump Installed Big Pharma Executives In Key Administration Posts. President Trump installed a former Eli Lily executive, Alex Azar, as his secretary of Health and Human Services and his appointment of Scott Gottlieb at FDA was described as “music to pharma’s ears.” Other pharma lobbyists writing Trump’s health policy include senior adviser at FDA, Keagan Lenihan, who joined the administration after lobbying for the drug distribution giant McKesson, former Gilead lobbyist, Joe Grogan, who reviews health care regulations at the Office of Management and Budget, and Deputy Assistant to the President for Domestic Policy Lance Leggitt, who has lobbied for a variety of drug-industry clients.

Trump’s Proposals Always Fall Far Short Of His Promises. President Trump promised that he would allow Medicare to use its buying power to negotiate drug prices directly with suppliers, but after meeting with pharmaceutical executives early in 2017, Trump abandoned that pledge, calling it “price fixing” that would hurt “smaller, younger companies.” The planned announcement to move some drugs from Medicare Part B, in which pharmaceuticals are purchased and administered by medical providers, to Part D, will do little to restrain the cost of prescription drugs for America’s seniors and falls far short of Trump’s promises.

Republican Health Care Sabotage Makes Prescription Drugs More Expensive For Millions. The Trump Administration wants to let states sell junky short-term health plans that skirt Affordable Care Act requirements. Typical short-term policies do not cover prescription drugs or maternity care, mental health care, preventive care, and other essential benefits. Not only that, but short term plans result in higher costs for people enrolled in full coverage plans as well as soaring premiums.

… WHILE PHARMACEUTICAL COMPANIES ARE RAKING IT IN

Pharmaceutical Companies Have Reaped Huge Benefits From The Trump Tax Bill. The Trump tax scam means billions of dollars in tax breaks for pharmaceutical companies. An Axios study found that 21 health care companies collectively expect to gain $10 billion in tax savings during 2018 alone. Most of the tax break windfall for health care companies is going toward share buybacks, dividends, acquisitions and paying down debt. According to Axios, nine pharmaceutical companies are are spending a combined $50 billion on new share buyback programs. All of the buybacks were announced during or after passage of the tax bill. Some drug companies are also increasing dividends for shareholders, with AbbVie increasing its cash dividend by 35 percent while also announcing a new $10 billion share repurchase program.

Massive Profits And Price Increases. Pharmaceutical companies raked in more than $30 billion in profits in the third quarter of 2018, with Pfizer alone bringing in $4.1 billion — the highest of any publicly traded healthcare company. Of the 19 companies that tallied at least $1 billion of third-quarter profit, 14 were drug companies.  Meanwhile, pharmaceutical companies continue to increase prices. In January 2019 alone, Pfizer and Novartis announced price increases on dozens of drugs, including increasing the cost of a breast cancer medication to $12,000 for 21 pills.  All in all, nearly 30 drugmakers are expected to raise prices in 2019.  

Soaring CEO Pay. According to an Axios study, the CEOs of 70 of the largest U.S. health care companies cumulatively have earned $9.8 billion since 2010. CEOs took home nearly 11 percent more money on average every year since 2010 — far more than the wage growth of nearly all other workers. In 2017 alone, 30 health care executives made a combined $976 million.

State of Broken Promises: Trump’s Talk is Cheap, but Prescription Drug Prices Aren’t

Washington DC — If past is prologue, tonight President Trump will once again pay lip service to rein in the high cost of prescription drugs, just as he did in last year’s State of the Union address. If the past year proves anything, it’s that President Trump’s talk is cheap but prescription drug prices remain sky high. Brad Woodhouse, executive director of Protect Our Care, issued the following statement in anticipation of more broken promises from Trump tonight on prescription drugs:

“One year ago, Donald Trump promised the American people he would ‘substantially’ lower prescription drugs prices and threw the gauntlet down by adding emphatically ‘watch.’ We did watch, Mr. President, and a year later prescription drug prices are still sky high. The president continues to renege on his campaign promise to allow Medicare to negotiate for lower drug prices, and his administration has put forward a plan on rebates that has been called a gift to Big Pharma. The only ‘substantial’ thing this President has done on health care in the last year is to engage in a relentless war on American health care administratively, in Congress, and in the courts. And if anyone believes some teleprompter-delivered promise from President Trump tonight on reducing the cost of prescription drugs, send them my way: I have some beachfront property in Arizona for sale.”

THE TRUMP ADMINISTRATION IS ALL TALK ON DRUG PRICES, BUT NO ACTION:

Drug Prices Continue to Soar Under Trump. A report by Senate Democrats finds that the prices of the 20 most-prescribed drugs under Medicare Part D have increased substantially over the past five years, rising 10 times faster than inflation. Another report from the Pharmacy Benefits Consultants finds that drug prices soared over the first 14 months of Trump’s presidency, during which 20 prescription drugs saw list-price increases of more than 200 percent. In 2018, there were about 1,800 prescription drug price increases according to data compiled by 46brooklyn Research. This year already, Pharma giants Pfizer and Novartis have raised prices on dozens of drug.

Trump Installed Big Pharma Executives In Key Administration Posts. President Trump installed a former Eli Lily executive, Alex Azar, as his secretary of Health and Human Services and his appointment of Scott Gottlieb at FDA was described as “music to pharma’s ears.” Other pharma lobbyists writing Trump’s health policy include senior adviser at FDA, Keagan Lenihan, who joined the administration after lobbying for the drug distribution giant McKesson, former Gilead lobbyist, Joe Grogan, who reviews health care regulations at the Office of Management and Budget, and Deputy Assistant to the President for Domestic Policy Lance Leggitt, who has lobbied for a variety of drug-industry clients.

Trump’s Proposals Always Fall Far Short Of His Promises. President Trump promised that he would allow Medicare to use its buying power to negotiate drug prices directly with suppliers, but after meeting with pharmaceutical executives early in 2017, Trump abandoned that pledge, calling it “price fixing” that would hurt “smaller, younger companies.” The planned announcement to move some drugs from Medicare Part B, in which pharmaceuticals are purchased and administered by medical providers, to Part D, will do little to restrain the cost of prescription drugs for America’s seniors and falls far short of Trump’s promises.

Republican Health Care Sabotage Makes Prescription Drugs More Expensive For Millions. The Trump Administration wants to let states sell junky short-term health plans that skirt Affordable Care Act requirements. Typical short-term policies do not cover prescription drugs or maternity care, mental health care, preventive care, and other essential benefits. Not only that, but short term plans result in higher costs for people enrolled in full coverage plans as well as soaring premiums.

… WHILE PHARMACEUTICAL COMPANIES ARE RAKING IT IN

Pharmaceutical Companies Have Reaped Huge Benefits From The Trump Tax Bill. The Trump tax scam means billions of dollars in tax breaks for pharmaceutical companies. An Axios study found that 21 health care companies collectively expect to gain $10 billion in tax savings during 2018 alone. Most of the tax break windfall for health care companies is going toward share buybacks, dividends, acquisitions and paying down debt. According to Axios, nine pharmaceutical companies are are spending a combined $50 billion on new share buyback programs. All of the buybacks were announced during or after passage of the tax bill. Some drug companies are also increasing dividends for shareholders, with AbbVie increasing its cash dividend by 35 percent while also announcing a new $10 billion share repurchase program.

Massive Profits And Price Increases. Pharmaceutical companies raked in more than $30 billion in profits in the third quarter of 2018, with Pfizer alone bringing in $4.1 billion — the highest of any publicly traded healthcare company. Of the 19 companies that tallied at least $1 billion of third-quarter profit, 14 were drug companies.  Meanwhile, pharmaceutical companies continue to increase prices. In January 2019 alone, Pfizer and Novartis announced price increases on dozens of drugs, including increasing the cost of a breast cancer medication to $12,000 for 21 pills.  All in all, nearly 30 drugmakers are expected to raise prices in 2019.  

Soaring CEO Pay. According to an Axios study, the CEOs of 70 of the largest U.S. health care companies cumulatively have earned $9.8 billion since 2010. CEOs took home nearly 11 percent more money on average every year since 2010 — far more than the wage growth of nearly all other workers. In 2017 alone, 30 health care executives made a combined $976 million.

Protect Our Care Statement On World Cancer Day

Washington DC — Today, the world comes together once again to recognize World Cancer Day. As we unite our voices to raise awareness, we also call on the Administration to end their attacks on pre-existing conditions and affordable comprehensive health care for cancer patients and survivors. Leslie Dach, chair of Protect Our Care, issued the following statement:

“Sadly, cancer has devastated the lives of millions of Americans and has left many wondering how they’ll access and pay for their life-saving care. Over the past two years, President Trump has worked nonstop to sabotage protections for coverage for pre-existing conditions, making life even more difficult for cancer patients and survivors.  The GOP lawsuit to “terminate” the ACA is President Trump’s latest attempt to roll back the clock and strip Americans of their health care. If this misguided ruling isn’t overturned, Republicans will succeed in striking down the ACA and gutting key protections for millions of Americans. On this World Cancer Day, Trump and his Republican allies ought to end their war on pre-existing conditions and instead put their efforts into fighting the war on cancer.”

Background:

  • As Outlined In An Amicus Brief Written By The American Cancer Society, The Affordable Care Act Has Increased Cancer Patients’ Access To Potentially Life-Saving Health Care. However, the ACA greatly improved this situation.  After the ACA was enacted, the uninsured rate among nonelderly patients with newly diagnosed cancer declined substantially, especially among low-income people who resided in Medicaid expansion states—where it decreased 6 percent. This increase in coverage affects health outcomes—a small but statistically significant shift was found toward early-stage diagnosis for colorectal, lung, female breast, and pancreatic cancer and melanoma in patients in expansion states. Similarly, the ACA coverage expansion for dependent children up to age 26 has increased the insurance coverage rate among that population, had positive effect on initiation and completion of the human papillomavirus (HPV) vaccination, early diagnosis and receipt of fertility-sparing treatments for cervical cancer, and increased early-stage diagnosis for total cancer and osseous and chondromatous neoplasms among young adults 19 to 25 years old. The proportion of cancer survivors reporting delayed or forgone care and inability to afford health care services also significantly decreased during implementation of the ACA from 2010 to 2016. Overall, the uninsured rate for cancer survivors decreased from 12.4 percent (pre-full ACA implementation, 2012) to 7.7 percent (post-full ACA implementation, 2015).” [American Cancer Society, 6/14/18]
  • Similarly, The Affordable Care Act’s Medicaid Expansion Has Helped Cancer Patients See Increased Coverage For Care. “The number of uninsured cancer patients dropped in both expanded and non-expanded states from 2011 to 2014, but expansion states experienced a steeper decline. In expanded states, the uninsured rate declined a relative 52 percent, from 4.4 to 2.1 percent while Medicaid enrollment rose from 15.2 to 18.0 percent (p < 0.0001). In non-expansion states, the uninsured rate dropped a relative five percent (8.4 to 8.0 percent).”  [American Society For Radiation Oncology, 9/25/17]
  • In Kentucky, Medicaid Expansion Was Associated With Earlier Diagnosis And Somewhat Improved Breast Cancer Care. “The expansion of Kentucky Medicaid in 2014 has been associated with earlier diagnosis and somewhat improved quality of breast cancer care, despite a stable disease incidence. Additional improvements in treatment expediency will require improvements in patient outreach and healthcare infrastructure.” [Journal of the American College of Surgeons, April 2018]

Shot/Chaser: Big Pharma Spends More On Lobbying Than Any Other Industry, Gets Rewarded With “Win” In Drug Rebate Proposal

Shot/Chaser: Big Pharma Spends More On Lobbying Than Any Other Industry, Gets Rewarded With “Win” In Drug Rebate Proposal

Big Pharma’s big spending in the last year is paying off with a new Trump administration proposal:

SHOT: Pharmaceutical Industry Spent More On Lobbying In 2018 Than Any Other Industry. Open Secrets issued a report showing that the pharmaceutical industry spent almost $280 million on lobbying in 2018, “with no other industry coming close” in terms of spending.

CHASER: “One Thing That Is Pretty Certain: Pharma Wins.” The Trump administration rolled out a new drug rebate proposal last Thursday, with Axios’ analysis concluding that it would just be another win for Big Pharma, with “no mandate to lower” drug prices for Americans.

New Trump Rule on Drug Rebates is Just a Gift to Big Pharma

Washington, DC– Yesterday, the Trump administration proposed a rule to the drug rebate system that they falsely claimed would help consumers and lower drug prices. Leslie Dach, chair of Protect Our Care, issued the following statement:

“This administration’s plan  – another multi-billion dollar giveaway to the big drug companies – will raise Medicare premiums with zero guarantees that it will lower costs for patients. Meanwhile, the administration opposes what really needs to happen — end drug company price gouging on everyday drugs like insulin that millions of Americans rely on, and let Medicare directly negotiate with drug companies to truly lower prices. With a former pharmaceutical executive running HHS, it’s no surprise the administration continues to side with big drug companies and ignore the needs of patients and older Americans.”

NEW NYT Interview, Trump Reveals Goal of Texas Lawsuit: “Terminate” Health Care

Washington DC — According to the newly released transcript of President Trump’s interview with The New York Times, Trump boasted that his Texas lawsuit will “terminate” the Affordable Care Act and that was a political “victory” for him and Republicans in Congress. Brad Woodhouse, executive director of Protect Our Care, issued the following statement in response:

“President Trump confirmed what we all know to be true: he and Republicans are using the Texas lawsuit to overturn the entire Affordable Care Act – eliminating all the protections for people with pre-existing conditions – with no plans for a replacement. Voters overwhelmingly rejected Trump’s health care repeal and sabotage agenda back in November, yet President Trump and his allies in Congress are dead set on accomplishing through the courts what they couldn’t do legislatively: fully repeal the law, devastate American health care and leave millions of Americans at risk.”

Protect Our Care Statement On Gallup Poll Showing The Uninsured Rate Jumping To The Highest Level In 5 Years

YEARS OF REPUBLICAN SABOTAGE RESULTS IN THE FEWEST PEOPLE COVERED SINCE THE PASSAGE OF THE ACA, HURTING WOMEN, LOWER-INCOME HOUSEHOLDS, AND YOUNG PEOPLE THE MOST

Washington DC — Today, according to a new Gallup Health and Wellbeing-Index, about 7 million fewer people had health care in 2018 compared to the previous year. The uninsured rate has steadily increased during the Trump administration from a low of 11 percent in 2016, the lowest since the passage of the Affordable Care Act (ACA). The rate was 14 percent in the last quarter of 2018. Brad Woodhouse, executive director of Protect Our Care, released the following statement:

“Years of Trump administration and Republican sabotage of the ACA continues to take its toll. The Trump administration regularly claims it’s making health care better, but the proof is in the pudding — he’s sabotaging the system and ripping coverage away from millions of families.  And Trump’s sabotage hits women, lower income households, and young people especially hard.

“President Trump and his allies in Congress must stop their partisan war on health care before they rip coverage away from millions more. Our focus should be on lowering costs and helping more people get coverage, but Republicans insist on taking us backwards – the exact approach voters rejected in November.  It’s past time for Congress to step in and put the brakes on Trump’s health care sabotage because millions of Americans are paying the price with less coverage and higher costs.”

BREAKING: Texas Judge Grants Motion To Stay Proceedings In GOP Lawsuit To Repeal ACA

Washington DC – Today, Judge Reed O’Connor, who sided with President Trump and Republicans to overturn the Affordable Care Act, issued a stay in the Texas, et. al. vs. United States, et. al. lawsuit and ruled that his ruling is immediately appealable. This decision will allow the Affordable Care Act to remain in place while the ruling is appealed. Brad Woodhouse, executive director of Protect Our Care issued the following statement in response:

“Today’s ruling should prevent the damage this lawsuit will cause to millions of Americans while the appeal process is underway. But despite the clear message from the November elections, that the American people want protections for pre-existing conditions and quality and affordable health coverage, Donald Trump and his Republican allies will continue to try and weaponize the courts to do what they couldn’t do legislatively or at the ballot box — repeal the ACA. If this misguided ruling isn’t overturned, Republicans will succeed at striking down the ACA and gutting key protections for millions of Americans. Make no mistake, this politically driven lawsuit remains an absolute disaster for Americans and their health care.”

BACKGROUND:

Due to Judge O’Connor’s ruling on December 14th, Republicans are one step closer to repealing the Affordable Care Act and eliminating key protections, unleashing — as the Trump Administration itself admitted in his court — “chaos” in our entire health care system. Under this ruling:

  • Marketplace tax credits and coverage for 10 million people: GONE.
  • Medicaid expansion currently covering 15 million people: GONE.
  • Protections for more than 130 million people with pre-existing conditions when they buy coverage on their own: GONE.
  • Allowing children to stay on their parents’ insurance until age 26: GONE.
  • Free annual wellness exams: GONE.
  • Ban on annual and lifetime limits: GONE.
  • Ban on insurance discrimination against women: GONE.
  • Contraception with no out-of-pocket costs: GONE.
  • Limit on out-of-pocket costs: GONE.
  • Requirement that insurance companies cover essential benefits like prescription drugs, maternity care, and hospitalization: GONE.
  • Improvements to Medicare, including reduced costs for prescription drugs: GONE.
  • Closed Medicare prescription drug donut hole: GONE.
  • Rules to hold insurance companies accountable: GONE.
  • Small business tax credits: GONE.

Ignoring Clear Lessons of the Midterm Elections, Republicans Celebrate Decision Ending Protections for Pre-Existing Conditions and Ripping Health Care Away from Millions

On Friday, hand-picked, conservative, right-wing federal District Court Judge Reed O’Connor ruled the entire Affordable Care Act unconstitutional. His decision would end protections for people with pre-existing conditions, re-institute lifetime limits on coverage, implement an age tax on older Americans, end Medicaid expansion, and take away coverage from tens of millions of Americans. In short, an absolute disaster for Americans and their health care.

Despite this, Republicans are praising the decision:

CNN: President Trump “Immediately Tweeted In Celebration.” “President Donald Trump, who campaigned in 2016 on a promise to undo Obamacare, was thwarted in Congress last year by a lone vote from the late Arizona Republican Sen. John McCain. Trump immediately tweeted in celebration on Friday and called on Congress to act. ‘As I predicted all along, Obamacare has been struck down as an UNCONSTITUTIONAL disaster! Now Congress must pass a STRONG law that provides GREAT healthcare and protects pre-existing conditions. Mitch and Nancy, get it done!’ Trump wrote. He later added, ‘Wow, but not surprisingly, ObamaCare was just ruled UNCONSTITUTIONAL by a highly respected judge in Texas. Great news for America!’” [CNN, 12/15]

Washington Examiner: Republicans Are Using The Ruling To Once Again Revive Repeal. “Republicans revived their calls to replace Obamacare in the wake of a federal judge declaring the healthcare law unconstitutional, but Democrats indicated they had no plans to abandon the legal battle ahead… Sarah Sanders, the White House press secretary, said Friday night that she expected it would land before the high court. ‘The judge’s decision vindicates President Trump’s position that Obamacare is unconstitutional,’ she said… The actions in the courts are another way that Republicans are aiming to undo the law. The latest ruling follows a slew of challenges Obamacare has faced both in Congress and in the courts since it passed.” [Washington Examiner, 12/15]

CMS Administrator Seema Verma: “Obamacare Has Been Struck Down.” “Obamacare has been struck down by a highly respected judge. The judge’s decision vindicates President Trump’s position that Obamacare is unconstitutional. Once again, the President calls on Congress to replace Obamacare and act to protect people with preexisting conditions…and provide Americans with quality affordable healthcare. We expect this ruling will be appealed to the Supreme Court. Pending the appeal process, the law remains in place.” [Seema Verma Twitter, 12/15]

House Energy and Commerce Chair Greg Walden: We Need New Health Care Legislation. “Energy and Commerce Committee Chairman Greg Walden, R-Ore., echoed the calls for new legislation. ‘We have a rare opportunity for truly bipartisan healthcare reform,’ he said.” [Washington Examiner, 12/15]

House Ways and Means Chair Kevin Brady: Ruling Was “No Surprise” Because ACA Was “Poorly Written, Crafted By Democrats Behind Closed Doors.” “No surprise. Poorly written, crafted by Democrats behind closed doors & stuffed with special interests that drove up health costs for millions of working Americans. Time to start over – both parties working together this time to LOWER costs.” [Kevin Brady Twitter, 12/15]

Texas Attorney General Ken Paxton: Ruling Lets Congress Replace “Failed Social Experiment” That Is The Affordable Care Act. “Meanwhile Texas Attorney General Ken Paxton is declaring victory. Paxton praised the ruling as halting an unconstitutional exertion of power by the federal government. ‘Our lawsuit seeks to effectively repeal Obamacare, which will give President Trump and Congress the opportunity to replace the failed social experiment with a plan that ensures Texans and all Americans will again have greater choice about what health coverage they need and who will be their doctor,’ said Paxton’s statement.” [Buzzfeed, 12/15]

The groundwork for the lawsuit was laid by the Trump Administration:

CNBC: While President Trump Was Unable To Repeal ACA, He Was “Able To Dismantle Key Parts Of It.” “While President Donald Trump was previously unable to repeal Obamacare, he was able to dismantle key parts of it that several health policy researchers are blaming for much of the drop in enrollment this year. He applauded the judge’s ruling in a tweet late Friday. White House Press Secretary Sarah Huckabee Sanders released a statement praising the ruling. ‘Obamacare has been struck down by a highly respected judge. The judge’s decision vindicates President Trump’s position that Obamacare is unconstitutional.’” [CNBC, 12/14]

Vice News: Lawsuit Only Possible Because Trump’s Department Of Justice “Made The Unusual Decision To Not Defend Existing Federal Law.” “The lawsuit to dismantle the program was led by political leaders from 20 conservative-leaning states that filed a complaint in February, arguing the law couldn’t constitutionally stand without the tax… The Justice Department made the unusual decision to not defend existing federal law, siding with the states instead. California’s attorney general, Xavier Becerra, is leading the defense of the health care law.” [Vice, 12/15]

Washington Times: The Trump Administration “Did Not Defend The Law In Court.” “The Trump administration did not defend the law in court, and sided with the states on some points. Yet it asked the judge to wait until open enrollment was complete, to avoid chaos in the markets. But that didn’t happen.” [Washington Times, 12/14]

And it is the American people would be left to suffer:

CBS News: Invalidated Law Would Mean The End Of Protections For People With Pre-Existing Conditions And The Ability Of Children To Stay On Their Parents’ Coverage Until Age 26. ““Democrats were able to retake the House in large part because they campaigned on health care issues, warning that Republicans would try to strip away some of the more popular provisions of the ACA, such as protection for pre-existing conditions. Around 130 million people in the United States have pre-existing conditions, and without the ACA, insurers would no longer be required to cover those conditions. If the law is invalidated, it could scrap other well-liked sections of the law, such as the part that allows parents to keep young adult children on their health care coverage until age 26.” [CBS News, 12/15]

Associated Press: Coverage For 20 Million Americans At Stake Under This Ruling. “About 20 million people have gained health insurance coverage since the law passed in 2010 without a single Republican vote. Currently, about 10 million have subsidized private insurance through the health law’s insurance markets, while an estimated 12 million low-income people are covered through its Medicaid expansion.” [AP, 12/15]

  • Fox News: Ruling “Could Suddenly Disrupt The Health Insurance Of Millions Of Americans.” “The Affordable Care Act, also known as Obamacare, was struck down by a Texas judge on Friday, a move that could suddenly disrupt the health insurance status of millions of Americans. The decision comes amid a six-week open enrollment period for the program.” [Fox News, 12/15]
  • CNN: Ruling “Throws Into Doubt The Future Of Health Coverage For Millions Of Americans.” “Legal experts say the ruling won’t immediately affect Americans’ health coverage, and a group of states led by California is already vowing to appeal. But the invalidation of the landmark health care law popularly known as Obamacare throws into doubt the future of health coverage for millions of Americans on the Obamacare exchanges and in Medicaid expansion.” [CNN, 12/15]

Politico: “Even The Trump Administration’s Own Plans To Lower Drug Prices” Would Be Illegal Under Ruling. “Expanded Medicaid for millions. Penalties for poorly performing hospitals. Even the Trump administration’s own plans to lower drug prices. Those and many other initiatives would all be illegal under a federal judge’s sweeping decision that the entire Affordable Care Act must be struck down — the latest shock to the nation’s health system after a decade of upheavals, including two fights over the ACA that reached the Supreme Court.” [Politico, 12/15]